Patent details
EP3512863 Title: 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT
Basic Information
- Publication number:
- EP3512863
- PCT Application Number:
- US2017050323
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP178494746
- PCT Publication Number:
- WO2018048937
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 2'-SUBSTITUTED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR RNA VIRUS TREATMENT
- French Title of Invention:
- 2'-SUBSTITUÉ-N6-SUBSTITUÉS NUCLÉOTIDES DE PURINE POUR LE TRAITEMENT DE VIRUS À ARN
- German Title of Invention:
- 2'-SUBSTITUIERTE-N6-SUBSTITUIERTE PURINNUKLEOTIDE ZUR BEHANDLUNG VON RNA-VIREN
- SPC Number:
Dates
- Filing date:
- 06/09/2017
- Grant date:
- 08/12/2021
- EP Publication Date:
- 24/07/2019
- PCT Publication Date:
- 15/03/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/12/2021
- EP B1 Publication Date:
- 08/12/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/09/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/12/2021
- Name:
- ATEA Pharmaceuticals, Inc.
- Address:
- 125 Summer Street, Boston, MA 02110, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 19/01/2022
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SOMMADOSSI, Jean-Pierre
- Address:
- United States (US)
2
- Name:
- MOUSSA, Adel
- Address:
- United States (US)
Priority
- Priority Number:
- 201662384664 P
- Priority Date:
- 07/09/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/675; A61K 31/7076; C07H 23/00; C07H 19/16; C07H 19/207; C07H 19/20; A61P 1/00; A61P 31/14;
Publication
European Patent Bulletin
- Issue number:
- 202149
- Publication date:
- 08/12/2021
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 9
- Annual Fee Amount:
- 115 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 29/08/2024
- Last Annual Fee Paid Number:
- 8
- Last Annual Fee Paid Amount:
- 99 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|---|---|
| 18/01/2022 | Power Of Attorney | 1 |
| 19/01/2022 | Outgoing Correspondence | 1 |